Across TCGA pan-cancer cohorts, SMIM15 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated SMIM15 data layer compared with 24 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher SMIM15 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SMIM15 expression acts as an unfavorable survival marker.

KIRP are the cancer types where SMIM15 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Median	All	0.135	0.703	.002	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: SMIM15 tumor-vs-normal RNA expression · all SMIM15 data types